Efficacy
BOR of SD
DISEASE
Although no objective responses were observed in this heavily pretreated study population, 7 (25.9%) patients had a BOR of SD (Percentage change from baseline of the sum of longest target lesion diameters. The dashed lines show thresholds for progressive disease and PR. Dose levels are represented by different colors and symbols; the different curves at each dose level represent different patients.